Genocea Biosciences, Inc.
US ˙ OTCPK

Introduction

This page provides a comprehensive analysis of the known insider trading history of Robert E Jr Farrell. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Robert E Jr Farrell has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:MORF / Morphic Holding, Inc. SVP Finance and CAO 0
US:GNCA / Genocea Biosciences Inc VP of Finance & Administration 17,019
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Robert E Jr Farrell. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases GNCAQ / Genocea Biosciences, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in GNCAQ / Genocea Biosciences, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GNCAQ / Genocea Biosciences, Inc. Insider Trades
Insider Sales GNCAQ / Genocea Biosciences, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in GNCAQ / Genocea Biosciences, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GNCAQ / Genocea Biosciences, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Robert E Jr Farrell as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-08-20 2024-08-16 4 MORF Morphic Holding, Inc.
Common Stock
D - Sale to Issuer -12,000 0 -100.00
2024-08-02 2024-08-02 4 MORF Morphic Holding, Inc.
Common Stock
G - Gift -2,000 11,781 -14.51
2024-07-10 2024-07-08 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -30,272 13,781 -68.72 55.80 -1,689,178 768,980
2024-07-10 2024-07-08 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 8,786 44,053 24.91 4.32 37,912 190,093
2024-01-17 2024-01-16 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale -5,089 34,992 -12.70 27.49 -139,900 961,955
2024-01-17 2024-01-14 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 3,470 40,081 9.48
2024-01-17 2024-01-13 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 12,675 36,611 52.95
2023-05-25 2023-05-23 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -10,000 23,708 -29.67 60.00 -600,000 1,422,480
2023-05-25 2023-05-23 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 10,000 33,708 42.18 4.32 43,200 145,619
2023-05-10 2023-05-08 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 11,486 23,708 93.98 4.32 49,620 102,419
2023-04-27 2023-04-25 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -10,000 12,222 -45.00 54.71 -547,100 668,666
2023-04-27 2023-04-25 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 10,000 22,222 81.82 4.32 43,200 95,999
2023-04-21 2023-04-20 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -10,000 12,222 -45.00 45.00 -450,000 549,990
2023-04-21 2023-04-20 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 10,000 22,222 81.82 4.32 43,200 95,999
2023-04-19 2023-04-19 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 10,000 12,222 450.05 4.32 43,200 52,799
2023-04-19 2023-04-17 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -10,000 2,222 -81.82 42.50 -425,001 94,435
2023-04-19 2023-04-17 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -10,000 12,222 -45.00 40.00 -400,000 488,880
2023-01-18 2023-01-14 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale -1,248 22,222 -5.32 30.63 -38,224 680,624
2023-01-18 2023-01-14 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 3,470 23,470 17.35
2022-01-19 2022-01-14 4 MORF Morphic Holding, Inc.
Restricted Stock Units (RSU)
A - Award 13,880 13,880
2022-01-19 2022-01-14 4 MORF Morphic Holding, Inc.
Stock Option (right to buy Common Stock)
A - Award 60,288 60,288
2021-11-03 2021-11-03 4 MORF Morphic Holding, Inc.
Stock Option (right to buy Common Stock)
M - Exercise -10,000 60,270 -14.23
2021-11-03 2021-11-03 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 10,000 20,000 100.00 4.32 43,200 86,400
2021-09-14 2021-09-13 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -3,049 10,000 -23.37 65.01 -198,202 650,056
2021-09-14 2021-09-10 4 MORF Morphic Holding, Inc.
Stock Option (right to buy Common Stock)
M - Exercise -4,974 70,270 -6.61
2021-09-14 2021-09-10 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -9,859 13,049 -43.04 65.14 -642,166 849,947
2021-09-14 2021-09-10 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 4,974 22,908 27.74 4.32 21,488 98,963
2021-06-21 2021-06-18 4 MORF Morphic Holding, Inc.
Stock Option (right to buy Common Stock)
M - Exercise -200 75,244 -0.27
2021-06-21 2021-06-18 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -200 17,934 -1.10 65.00 -13,000 1,165,710
2021-06-21 2021-06-18 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 200 18,134 1.12 4.32 864 78,339
2021-06-21 2021-06-16 4 MORF Morphic Holding, Inc.
Stock Option (right to buy Common Stock)
M - Exercise -300 75,444 -0.40
2021-06-21 2021-06-16 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -300 17,934 -1.65 65.00 -19,501 1,165,769
2021-06-21 2021-06-16 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 300 18,234 1.67 4.32 1,296 78,771
2021-06-14 2021-06-14 4 MORF Morphic Holding, Inc.
Stock Option (right to buy Common Stock)
M - Exercise -3,526 75,744 -4.45
2021-06-14 2021-06-14 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -3,526 17,934 -16.43 65.00 -229,200 1,165,760
2021-06-14 2021-06-14 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 3,526 21,460 19.66 4.32 15,232 92,707
2021-06-14 2021-06-10 4 MORF Morphic Holding, Inc.
Stock Option (right to buy Common Stock)
M - Exercise -16,000 79,270 -16.79
2021-06-14 2021-06-10 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -16,000 17,934 -47.15 60.08 -961,219 1,077,407
2021-06-14 2021-06-10 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 16,000 33,934 89.22 4.32 69,120 146,595
2021-02-03 2021-02-03 4 MORF Morphic Holding, Inc.
Stock Option (right to buy Common Stock)
M - Exercise -15,000 95,270 -13.60
2021-02-03 2021-02-03 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -2,954 17,934 -14.14 38.59 -114,005 692,136
2021-02-03 2021-02-03 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -12,046 20,888 -36.58 38.04 -458,280 794,667
2021-02-03 2021-02-03 4 MORF Morphic Holding, Inc.
Common Stock
M - Exercise 15,000 32,934 83.64 4.32 64,800 142,275
2021-02-03 2021-02-02 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -399 17,934 -2.18 37.11 -14,808 665,579
2021-02-03 2021-02-02 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -3,683 18,333 -16.73 36.59 -134,779 670,892
2021-02-03 2021-02-02 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -5,918 22,016 -21.19 35.51 -210,148 781,788
2021-01-19 2021-01-15 4 MORF Morphic Holding, Inc.
Stock Option (right to buy Common Stock)
A - Award 75,000 75,000
2020-12-30 2020-12-30 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -7,364 27,934 -20.86 32.56 -239,781 909,565
2020-12-30 2020-12-28 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -405 35,298 -1.13 33.12 -13,414 1,169,105
2020-12-30 2020-12-28 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -12,231 35,703 -25.52 32.28 -394,842 1,152,568
2020-11-12 2020-11-10 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -5,040 47,934 -9.51 28.12 -141,727 1,347,928
2020-11-12 2020-11-09 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -800 52,974 -1.49 28.00 -22,400 1,483,272
2020-10-27 2020-10-26 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -100 53,774 -0.19 29.31 -2,931 1,576,116
2020-10-27 2020-10-26 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -1,660 53,874 -2.99 28.16 -46,749 1,517,205
2020-10-27 2020-10-23 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -2,300 55,534 -3.98 28.31 -65,110 1,572,095
2020-10-21 2020-10-19 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -100 57,834 -0.17 28.05 -2,805 1,622,244
2020-10-13 2020-10-12 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -1,149 57,934 -1.94 27.02 -31,048 1,565,487
2020-10-13 2020-10-09 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -1,916 59,083 -3.14 26.75 -51,261 1,580,724
2020-10-08 2020-10-08 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -1,915 60,999 -3.04 26.71 -51,149 1,629,259
2020-10-08 2020-10-07 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -2,558 62,914 -3.91 26.69 -68,273 1,679,168
2020-10-08 2020-10-07 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -4,026 65,472 -5.79 25.69 -103,413 1,681,733
2020-10-08 2020-10-06 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -100 69,498 -0.14 26.93 -2,693 1,871,581
2020-10-08 2020-10-06 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -1,215 69,598 -1.72 26.32 -31,980 1,831,896
2020-10-05 2020-10-05 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -2,000 70,813 -2.75 26.56 -53,119 1,880,758
2020-10-05 2020-10-02 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -813 72,813 -1.10 26.64 -21,661 1,939,935
2020-10-05 2020-10-02 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -1,029 73,626 -1.38 25.76 -26,504 1,896,422
2020-10-05 2020-10-01 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale X -3,279 74,655 -4.21 27.61 -90,537 2,061,307
2020-06-01 2020-06-01 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale -6,681 77,934 -7.90 20.35 -135,972 1,586,121
2020-06-01 2020-05-29 4 MORF Morphic Holding, Inc.
Common Stock
S - Sale -13,319 84,615 -13.60 20.17 -268,672 1,706,862
2020-02-19 2020-02-18 4 MORF Morphic Holding, Inc.
Stock Option (right to buy Common Stock)
A - Award 87,500 87,500
2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock
195,868
2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock
195,868
2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock
195,868
2014-02-24 2014-02-20 4 GNCA GENOCEA BIOSCIENCES, INC.
Option to purchase Common Stock
A - Award 17,019 17,019
2014-02-06 2014-02-04 4 GNCA GENOCEA BIOSCIENCES, INC.
Option to purchase Common Stock
A - Award 1,409 1,409
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)